Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Unit for $45 Million in Cash

07:37 AM EDT, 09/02/2026 (MT Newswires) -- Fortrea (FTRE) has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials for $45 million in cash. The acquisition includes a 60,000 square-foot lab in Austin, a 200-bed clinical pharmacology unit in San Antonio, and a biospecimen storage facility in Pflugerville, Texas, the company said. The transaction is expected to follow clearing of necessary regulatory and license requirements, the company said. Shares of Fortrea were down 2.6% in recent Wednesday premarket activity.